HELOCYTE
Live / Registered — Registered and renewed (as of 08 Dec 2025)
What this means for you
Registered since 09 Aug 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Aug 2026).
Record
- Serial number
- 86680734
- Registration number
- 5019023
- Mark type
- Stylized text
- Filed
- 01 Jul 2015
- Published for opposition
- 24 Nov 2015
- Registered
- 09 Aug 2016
- Next maintenance due
- 09 Aug 2026
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; pharmaceutical research and development; biotechnology research and development; biopharmaceutical research and development; provision of scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Helocyte, Inc., Bay Harbor Islands, FL, US
- Helocyte, Inc., New York, NY, US
- Helocyte, Inc., New York, NY, US
Prosecution history
- 08 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 08 Dec 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 08 Dec 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2025 — TEAS SECTION 8 & 9 RECEIVED
- 09 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Nov 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Aug 2021 — TEAS SECTION 8 & 15 RECEIVED
- 09 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jul 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2016 — STATEMENT OF USE PROCESSING COMPLETE